Search Results - "Juttner, C."
-
1
The biology and clinical uses of blood stem cells
Published in Blood (01-04-1997)Get full text
Journal Article -
2
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy
Published in The Lancet (British edition) (14-03-1992)“…The haemopoietic growth factor granulocyte colony-stimulating factor (G-CSF; filgrastim) substantially shortens the period of severe neutropenia that follows…”
Get more information
Journal Article -
3
A Comparative Study of the Phenotype and Proliferative Capacity of Peripheral Blood (PB) CD34+ Cells Mobilized by Four Different Protocols and Those of Steady-Phase PB and Bone Marrow CD34+ Cells
Published in Blood (01-11-1994)“…Peripheral blood (PB) CD34+ cells from four commonly used mobilization protocols were studied to compare their phenotype and proliferative capacity with…”
Get full text
Journal Article -
4
Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage
Published in Blood (15-09-1992)“…Hematopoietic reconstitution (HR) after peripheral blood stem cell transplantation is characterized by a delay of 8 and 12 days for recovery to safe levels of…”
Get full text
Journal Article -
5
Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation
Published in Bone marrow transplantation (Basingstoke) (01-11-1993)“…The rate and pattern of recovery of total lymphocytes, T cell subsets, B cells and NK cells were compared for 12 months following recovery phase peripheral…”
Get more information
Journal Article -
6
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants
Published in Bone marrow transplantation (Basingstoke) (01-04-1992)“…The haematological recovery time, infection rate and supportive care requirements of patients receiving recovery phase autologous peripheral blood stem cell…”
Get more information
Journal Article -
7
Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma
Published in Blood (15-06-1998)“…Unfractionated peripheral blood stem cell (PBSC) grafts contain measurable quantities of myeloma cells and are therefore a potential source of relapse…”
Get full text
Journal Article -
8
Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma
Published in Blood (15-06-1998)“…Unfractionated peripheral blood stem cell (PBSC) grafts contain measurable quantities of myeloma cells and are therefore a potential source of relapse…”
Get full text
Journal Article -
9
Evaluation of the potential causes of epistaxis in dogs with natural visceral leishmaniasis
Published in Veterinary record (11-08-2001)“…Haemostasis was evaluated in 19 dogs with natural Leishmania infection, six of them with a history of epistaxis, and the results were compared with the results…”
Get full text
Journal Article -
10
Expression of the YB5.B8 Antigen (c-kit proto-oncogene product) in Normal Human Bone Marrow
Published in Blood (01-07-1991)“…The c-kit proto-oncogene product is a member of the family of growth factor receptors with intrinsic tyrosine kinase activity. In the mouse c-kit maps to the W…”
Get full text
Journal Article -
11
c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture
Published in Experimental hematology (01-02-1994)“…Using monoclonal antibody (MAB) YB5.B8, we have examined the expression of the c-kit protein, the receptor for the hematopoietic cytokine stem cell factor…”
Get more information
Journal Article -
12
Partially Differentiated Ex Vivo Expanded Cells Accelerate Hematologic Recovery in Myeloablated Mice Transplanted With Highly Enriched Long-Term Repopulating Stem Cells
Published in Blood (01-11-1996)“…The ability of an infusion of ex vivo expanded hematopoietic cells to ameliorate cytopenia following transplantation of hematopoietic stem cells (HSCs) is…”
Get full text
Journal Article -
13
Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests
Published in British journal of haematology (01-03-1996)“…lt could be speculated for patients with myeloma and other lymphoproliferative disorders that peripheral blood stem cells may be preferable to bone marrow for…”
Get more information
Journal Article -
14
Optimal conditions for simultaneous measurement of platelet aggregation and ATP secretion in canine whole blood
Published in Research in veterinary science (01-02-2000)“…This paper describes the optimal conditions for simultaneous evaluation of platelet aggregation and secretion capacity in canine whole blood using a Whole…”
Get full text
Journal Article -
15
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood
Published in Experimental hematology (01-06-1990)“…We used single high doses of cyclophosphamide (4 g/m2) to produce rebound increases in peripheral blood (PB) stem cells (PBSC) during recovery from…”
Get more information
Journal Article -
16
Stimulation of proliferation, differentiation, and function of human cells by primate interleukin 3
Published in Proceedings of the National Academy of Sciences - PNAS (01-05-1987)“…Cloned gibbon interleukin 3 (gIL-3) was found to stimulate the proliferation and differentiation of human bone marrow cells to produce day-14 granulocyte,…”
Get full text
Journal Article -
17
Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells
Published in Clinical cancer research (01-07-1995)“…Women with primary breast cancer associated with extensive axillary node involvement or large primary tumors have a very poor prognosis despite treatment with…”
Get full text
Journal Article -
18
Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies
Published in Bone marrow transplantation (Basingstoke) (01-07-1994)“…The hemopoietic growth factor filgrastim (r-metHu G-CSF) stimulates granulopoiesis after autologous BMT and can also be used as a peripheral blood progenitor…”
Get more information
Journal Article -
19
Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy
Published in British journal of haematology (01-12-1985)“…Haemopoietic reconstitution (HR) using autologous peripheral blood stem cells (PBSC) was attempted after intensive chemotherapy or chemoradiotherapy in two…”
Get more information
Journal Article -
20
Apoptosis regulatory gene NEDD2 maps to human chromosome segment 7q34-35, a region frequently affected in haematological neoplasms
Published in Human genetics (01-06-1995)“…Developmentally regulated mouse gene Nedd2 encodes a protein similar to the product of the nematode Caenorhabditis elegans cell death gene ced-3 and the…”
Get full text
Journal Article